4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-031386
SVP, Chief Accounting Officer sold 142 shares at $113.67 ($16,141)
From the SEC's structured data for this filing
Trades in this filing
Huizenga Theodore Alan · SVP, Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-06 | Sale : show line 1 in the form | −142 | $113.67 | $16,141 | 15,031 | D |
| Open-market sales · 142 sh · avg $113.67 · $16,141 | ||||||
Loading xslF345X03/doc4.xml…